STOCKSCREENR

HEPA

NASDAQ

Hepion Pharmaceuticals, Inc.

$0.04-0.00(-2.20%)Mkt Cap: $465.98K

Key Stats

Market Cap

$465.98K

P/E Ratio

-0.05

EPS

$-0.88

Dividend Yield

0.00%

52-Week Range

$0.03 — $0.49

Volume

3

Avg Volume

12.62K

Beta

1.61

Price Alerts for HEPA

Get alerted when HEPA hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-0.05

Forward P/E

—

PEG Ratio

-0.00

P/S (TTM)

0.00

P/B (TTM)

0.13

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-2.42%

ROA (TTM)

-2.70%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

0.02

Current Ratio

10.25

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.17%

EPS Growth (5Y)

+0.39%

Sales Growth (3Y)

+0.00%

Sales Growth (5Y)

+0.00%

EPS Est (This Year)

$-472.00

EPS Est (Next Year)

$-468.00

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.19

Analyst Consensus

Ownership

Institutional %

0.80%

Inst. Net Change

1

Insider Net Shares (90d)

—

Outstanding Shares

11.62M

Float

11.62M

Free Float %

100.00%

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

IPO Date

2014-02-10

Employees

22

CEO

Gary S. Stetz

Index Membership

—

Website

https://www.hepionpharma.com

Hepion Pharmaceuticals, Inc. (HEPA) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $465.98K, a P/E ratio of -0.05, HEPA is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare HEPA against other stocks using dozens of fundamental and technical filters.

Similar Stocks

IBO.V

Universal Ibogaine Inc.

$0.01

-50.00%

$1.56M

AIM

AIM ImmunoTech Inc.

$0.52

-0.64%

$1.75M

BRTX

BioRestorative Therapies, Inc.

$0.23

+3.60%

$2.10M

CARM

Carisma Therapeutics, Inc.

$0.04

+0.53%

$1.58M

CLDI

Calidi Biotherapeutics, Inc.

$0.22

-8.69%

$1.59M

WINT

Windtree Therapeutics, Inc.

$0.01

-10.00%

$455.07K

Frequently Asked Questions

What is Hepion Pharmaceuticals, Inc.'s P/E ratio?

Hepion Pharmaceuticals, Inc. (HEPA) has a trailing twelve-month (TTM) P/E ratio of -0.05. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Hepion Pharmaceuticals, Inc. pay a dividend?

No, Hepion Pharmaceuticals, Inc. (HEPA) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Hepion Pharmaceuticals, Inc.'s market cap?

Hepion Pharmaceuticals, Inc. (HEPA) has a market capitalization of $465,975, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.